Safety of Abemaciclib in Indian Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced and/or Metastatic Breast Cancer: A Multicenter, Nonrandomized, Open-Label, Single-Arm, Phase 4 Study.
- DOI
- 10.1055/s-0045-1802565
- Published
- 2025 Jul
- Container
- South Asian journal of cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1055/s-0045-1802565,
title = {Safety of Abemaciclib in Indian Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced and/or Metastatic Breast Cancer: A Multicenter, Nonrandomized, Open-Label, Single-Arm, Phase 4 Study.},
author = {Doval DC and Maksud T and Nagarkar R and Thunagappa SC and Taran R and Prasad S and Manoharan AT and Jain M and Mehta D and Mohapatra PN and Gupta S and Singh KN and Pruthi A and Arora R},
year = {2025},
journal = {South Asian journal of cancer},
doi = {10.1055/s-0045-1802565},
url = {https://doi.org/10.1055/s-0045-1802565}
}RIS
TY - JOUR TI - Safety of Abemaciclib in Indian Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced and/or Metastatic Breast Cancer: A Multicenter, Nonrandomized, Open-Label, Single-Arm, Phase 4 Study. AU - Doval DC AU - Maksud T AU - Nagarkar R AU - Thunagappa SC AU - Taran R AU - Prasad S AU - Manoharan AT AU - Jain M AU - Mehta D AU - Mohapatra PN AU - Gupta S AU - Singh KN AU - Pruthi A AU - Arora R PY - 2025 JO - South Asian journal of cancer DO - 10.1055/s-0045-1802565 UR - https://doi.org/10.1055/s-0045-1802565 ER -
APA
DC, D., T, M., R, N., SC, T., R, T., S, P., AT, M., M, J., D, M., PN, M., S, G., KN, S., A, P., & R, A. (2025). Safety of Abemaciclib in Indian Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced and/or Metastatic Breast Cancer: A Multicenter, Nonrandomized, Open-Label, Single-Arm, Phase 4 Study.. South Asian journal of cancer. https://doi.org/10.1055/s-0045-1802565
Source records
- pubmed · retrieved 2026-09-25T08:17:46.715Z